Cargando…
Audiological Evaluation of Patients Taking Kanamycin for Multidrug Resistant Tuberculosis
INTRODUCTION: The incidence of multidrug resistant tuberculosis is increasing in developing countries. Aminoglycosides are an integral part of second-line drugs, however ototoxicity is a major limitation for their use. This study aims to determine the extent of hearing loss in patients taking one of...
Autores principales: | Sharma, Vishal, Bhagat, Sanjeev, Verma, Bhimsain, Singh, Ravinder, Singh, Surinderpal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930843/ https://www.ncbi.nlm.nih.gov/pubmed/27429949 |
Ejemplares similares
-
Effect of lidocaine on kanamycin injection-site pain in patients with multidrug-resistant tuberculosis
por: Court, R. G., et al.
Publicado: (2018) -
The efficacy of bedaquiline versus kanamycin in multi-drug resistant tuberculosis: A systematic scoping review
por: Singh, Lisa, et al.
Publicado: (2021) -
Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort
por: Sagwa, Evans L., et al.
Publicado: (2015) -
Evaluation of Genetic Mutations Associated with Mycobacterium tuberculosis Resistance to Amikacin, Kanamycin and Capreomycin: A Systematic Review
por: Georghiou, Sophia B., et al.
Publicado: (2012) -
Prevalence of multidrug-resistant tuberculosis among Category II pulmonary tuberculosis patients
por: Sharma, Surendra K., et al.
Publicado: (2011)